Open access · OA
via OpenAlex
The Diversity of Gut Microbiome is Associated With Favorable Responses to Anti–Programmed Death 1 Immunotherapy in Chinese Patients With NSCLC
Yueping Jin, Hui Dong, Liliang Xia, Yi Yang, Yongqiang Zhu, Yan Shen, Huajun Zheng, Chengcheng Yao, Ying Wang, Shun Lü
Journal of Thoracic Oncology · 2019 · ▲ 560 citations
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1016/j.jtho.2019.04.007
- Canonical
- link ↗
- Fetched
- 2026-06-13 MST
Cite this
APA
Jin, Y., Dong, H., Xia, L., Yang, Y., Zhu, Y., Shen, Y., Zheng, H., Yao, C., Wang, Y., & Lü, S. (2019). The Diversity of Gut Microbiome is Associated With Favorable Responses to Anti–Programmed Death 1 Immunotherapy in Chinese Patients With NSCLC. <em>Journal of Thoracic Oncology</em>. https://doi.org/10.1016/j.jtho.2019.04.007
Vancouver
Jin Y, Dong H, Xia L, Yang Y, Zhu Y, Shen Y, et al. The Diversity of Gut Microbiome is Associated With Favorable Responses to Anti–Programmed Death 1 Immunotherapy in Chinese Patients With NSCLC. Journal of Thoracic Oncology. 2019. doi:10.1016/j.jtho.2019.04.007.
BibTeX
@article{yueping2019TheDiv,
title = {The Diversity of Gut Microbiome is Associated With Favorable Responses to Anti–Programmed Death 1 Immunotherapy in Chinese Patients With NSCLC},
author = {Yueping Jin and Hui Dong and Liliang Xia and Yi Yang and Yongqiang Zhu and Yan Shen and Huajun Zheng and Chengcheng Yao and Ying Wang and Shun Lü},
journal = {Journal of Thoracic Oncology},
year = {2019},
doi = {10.1016/j.jtho.2019.04.007},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Journal of Diabetes Research 2018
Open access · CC-BY
Obesity-Linked Gut Microbiome Dysbiosis Associated with Derangements in Gut Permeability and Intestinal Cellular Homeostasis Independent of Diet
Journal for ImmunoTherapy of Cancer 2019
Open access · CC-BY
Gut microbiome affects the response to anti-PD-1 immunotherapy in patients with hepatocellular carcinoma
BMC Microbiology 2022
Open access · CC-BY
Dysbiosis of skin microbiome and gut microbiome in melanoma progression
Critical Care 2019
Open access · CC-BY
Dysbiosis of the intestinal microbiota in neurocritically ill patients and the risk for death
Experientia supplementum 2018
Citation only
Microbiome and Gut Dysbiosis
Translational research 2020
Open access · OA